5 Takeaways from FDAs Draft Guidance | Resources | Robins Kaplan LLP Law Firm

March 21, 2016

Read the full article (MDDI DeviceTalk) >

Data are becoming an increasingly integral component of medical technologies, including medical devices. However, the sensitive nature of healthcare data increases the risk that device companies and their partners will be targets of cyberattacks and heightens the consequences of a breach.

The FDA’s guidance doesn't cover all regulatory risks related to cyberattacks and provides no safe harbor for device makers.

+ READ MORE - READ LESS

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

MDDI DeviceTalk

Ryan W. Marth

Partner

Richard Martinez

August 19, 2019

INSIGHT: Being Prepared for a Ransomware Demand—Five Questions to Answer Now

Bloomberg Law

April 2018

Safeguarding Information Theft by Departing Employees

Industry Today

July 10, 2017

The Future Is Now: Biometric Information and Data Privacy

Antitrust

February 21, 2017

Van Patten V. Vertical Fitness Is No TCPA Killer

Law360

July 25, 2016

How to Create Your Cyber-Incident Response Plan

InsideCounsel

March 27, 2019

Robins Kaplan Attorneys Earn 2019 Readers' Choice Awards from JD Supra

Back to Top

Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.

If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.

By accepting these terms, you are confirming that you have read and understood this important notice.